Company

Akamis Bio

Biotechnology Research Abingdon, Oxfordshire, United Kingdom 37 employees

Employees: 37
Contacts: 1
Emails: 1
Phones: 1

+www.akamisbio.com LinkedIn Crunchbase

Akamis Bio Overview

Headquarters: Abingdon, Oxfordshire, United Kingdom
Website: +www.akamisbio.com
Industry: Biotechnology Research
Employees: 37
Founded: 2010
Funding: 60.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immuno-oncology and Re-programming the Tumor Microenvironment

About Akamis Bio

Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com.

Akamis Bio Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Akamis Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rob Maietta	Vice President, Head of Clinical	Tampa, Florida, United States	Email Phone
Paolo Paoletti, Md	CEO of Gammadeltatherapeutics Ltd		View
John Hayes	Biotech Finance Executive	Newton, Massachusetts, United States	View
CHRO Faisal Beg	CEO & Founder at Sch Co, for Pr	Sulaymaniyah District, Sulaymaniyah Governorate, Iraq	View